WMTC1498

Vijaya Diagnostic Centre
H.No.6-3-28/29, Beside Joyalukkas Jewellers, Hanamkonda.
LABORATORY TEST REPORT

Regn Date : 02/11/2019 08:56 Sample Collection : 02/11/2019 09:01
Name : MR. N HARI KRISHNA Print Date : 02/11/2019 22:52
Regn No : 401975639 Age / Sex : 46 Years / Male
Ref By : SELF Regn Centre : Hanamkonda - 40
Sample Type : Serum Ref no. :
URIC ACID
TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL
Uric Acid : 8.1 3.5 - 7.2 mg/dL

Method : Uricase PAP
Comments / Interpretation :
----------------------------------
- Useful for monitoring therapeutic management of gout and chemotherapeutic treatment of neoplasms.
CALCIUM
Serum Calcium : 9.1 8.8 - 10.6 mg/dL

Method:Arsenazo III
--------------------------------
- Useful in diagnosis and prognosis of a wide range of disorders including disorders of proteins and Vitamin D, diseases of bone,
Kidney, Parathyroid gland and GI tract.
CREATININE
Creatinine : 2.0 Adult Male : 0.7 - 1.2 mg/dL

Neonate : 0.3 - 1.0 mg/dL
Infant : 0.2 - 0.4 mg/dL
Children : 0.3 - 0.8 mg/dL mg/dL
-------------------------------
- Useful in the diagnosis of renal insufficiency and is more specific and sensitive indicator of renal disease than of BUN.
- Use of simultaneous BUN and creatinine levels provide more information in the diagnosis of renal insufficiency.
UREA SERUM
Urea : 45 Adults: 17-43mg/dL

New born: 8.4-25.8 mg/dL
Infant: 10.8-38.4 mg/dL
Method :Glutamate - dehydrogenase (GLDH) Kinetic Assay
---------------------------------
- In conjunction with serum creatinine, urea level aid in differential diagnosis of Pre-Renal, Renal and Post-Renal hyperuremia.
PSA ONLY FOR MEN (PROSTATE SPECIFIC ANTIGEN)
Released Date 02/11/2019 11:17 Page 1 of 12

*401975639* NABL Accredited

PSA ONLY FOR MEN (PROSTATE SPECIFIC ANTIGEN)

Serum Prostatic Specific Antigen : 1.92 <4.0 ng/mL

Method : Chemiluminescence Immunoassay (CLIA)
---------------------------------
- Useful in monitoring patients with a history of Carcinoma prostate and as a prognostic marker
- PSA levels are increased in Prostatitis,Cancer,Benign Prostatic hyperplasia, Acute Urinary retention,
Urinary Tract Infection (UTI) and Vigorous Exercise.
Dr NARENDER G MD
Certificate # MC-2025 CONSULTANT BIOCHEMIST


Sample Type : Fluoride Plasma Ref no. :
FASTING PLASMA GLUCOSE (FPG)

Fasting Plasma Glucose : 103 Normal : 70-100 mg/dL

Impaired Fasting Glucose : 101-125 mg/dL
Diabetes : >/=126 mg/dL
Method : Hexokinase
---------------------------------
- ADA Guidelines (2019) are adopted for the evaluation of Diabetic Status.
DR.PRADEEP
Certificate # MC-2025 CONSULTANT PATHOLOGIST


Sample Type : Whole Blood - EDTA Ref no. :
BLOOD GROUPING & Rh TYPING

ABO Group : "O"
Rh Typing : Positive
Method : Forward and Reverse Tube Agglutination
----------------------------------
- Reconfirm the Blood Group & Rh Typing along with cross matching before blood transfusion.
- Recent blood transfusion, if any, interferes with interpretation of blood grouping.
- The blood group and Rh antigen may change in the new born, hence please repeat the test after 6 months.
- Subgroups and Bombay blood group needs to be further verified.
DR.PRADEEP


Hepatitis B Surface Antigen (HBsAg) - Rapid

HBsAg (Spot) : Negative NA

Method : Immuno chromatography
Interpretation
-------------------------------------------------------------------------------------------------------------------------------------
Nonreactive Specimen is negative for HBsAg or Hepatitis B Virus surface antigens have not yet reached
detectable levels.
-------------------------------------------------------------------------------------------------------------------------------------
Reactive Specimen is positive for Hepatitis B surface Antigen .
------------------------------------------------------------------------------------------------------------------------------------
* This is a rapid test designed for qualitative determination of HBsAg in human serum.
* This test is a screening assay; it should not be used as a sole criterion for confirmation of Hepatitis B infection.
* Test results should be interpreted in conjunction with other HBV serologic markers like (eg, anti-HBs Ab,
anti-HBc Total and anti-HBc IgM, HBeAg & Anti HBe Ab) and patient symptoms.
* Individuals who have recently received Hepatitis B vaccination may have transient positive HBsAg test results
because of the large dose of HBsAg used in the vaccine.
DR.PRADEEP


LIPID PROFILE (LP)

Serum Status : Clear
Triglycerides : 171 Desirable Level : < 150 mg/dL

Borderline : 150 - 199 mg/dL
High : 200 - 499 mg/dL
Very High : > 500 mg/dL
Method : GPO-POD
Total Cholesterol : 243 Desirable Level : < 200 mg/dL

Borderline : 200 - 240 mg/dL
Undesirable : > 240 mg/dL
Method : Cholesterol oxidase peroxidase (CHOD-POD)
LDL Cholesterol. : 174 Optimal : < 100 mg/dL

Near Optimal : 100 - 129 mg/dL
Borderline High : 130 - 159 mg/dL
High : 160 - 189 mg/dL
Very High : > 190 mg/dL
Method: Calculation
HDL Cholesterol : 35 Desirable Level : > 60 mg/dL

Optimal : 40 - 59 mg/dL
Undesirable : < 40 mg/dL
Method : Enzymatic Immunoinhibition
VLDL : 34 < 30 mg/dL

Method: Calculation
Total Cholesterol/HDL Cholesterol Ratio : 6.94 Low Risk : 3.3 - 4.4

Average Risk : 4.5 - 7.1
Moderate Risk : 7.2 - 11.0
Method: Calculation
LDL Cholesterol/HDL Cholesterol Ratio : 4.97 Desirable Level : 0.5 - 3.0

Borderline Risk : 3.0 - 6.0
High Risk : > 6.0
Method: Calculation
---------------------------------
- Lipid profile is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, the
results of this tests can identify certain genetic diseases and can determine approximate risks for cardiovascular disease,
certain forms of pancreatitis and other diseases.
DR.PRADEEP


LIVER FUNCTION TEST - A (LFT-A)

Total Bilirubin : 1.3 0.3 - 1.2 mg/dL

Method : Dichlorophenyl Diazonium Tetrafluroborate
Conjugated Bilirubin : 0.2 Less than 0.2 mg/dL

Method : Dichlorophenyl Diazonium Tetrafluroborate
Unconjugated Bilirubin : 1.1 0.3 - 1.00 mg/dL

Method : Calculation
ALT/SGPT : 13 Male (Adult) : 0 - 50 U/L

Newborn/Infant : 13 - 45 U/L U/L
Method : IFCC without Pyridoxal Phosphate activation
AST/SGOT : 14 Male (Adult) : 0 - 50 U/L

Newborn : 25 - 75 U/L
Infant : 15 - 60 U/L U/L
Method : IFCC without Pyridoxal Phosphate activation
Alkaline Phosphatase : 95 30 - 120 U/L

Method : IFCC AMP (Amino Methyl Propanol) Buffer
Total Protein (TP) : 7.2 6.6 - 8.3 g/dL

Method : Biuret
Albumin : 4.2 Adult : 3.5 - 5.2 g/dL

New Born (0-4 days) : 2.8 - 4.4 g/dL
Method : Bromocresol Green (BCG)
Globulin : 3.0 1.8 - 3.6 g/dL

Albumin / Globulin (A/G) Ratio : 1.4 0.8 - 2.0

Gamma-Glutamyl Transferase (GGT) : 34 0 - 55 U/L

Method : IFCC UV Kinetic
---------------------------------
- Liver function test aid in the diagnosis of various pre hepatic, hepatic & post hepatic causes of dysfunction like hemolytic
anemias, viral & alcoholic hepatitis and cholestasis of obstructive causes.
- The test encompasses hepatic excretory, synthetic function and also hepatic parenchymal cell damage.
- LFT helps in evaluating severity, monitoring therapy and assessing prognosis of liver disease and dysfunction.
DR.PRADEEP


Sample Type : Urine Ref no. :
CUE (COMPLETE URINE EXAMINATION)

Macroscopic Examination
Colour : Pale Yellow Pale Yellow

.
Appearance : Clear Clear

.
Specific Gravity : 1.015 1.003 - 1.030

Ion Exchange
Reaction/pH : Acidic (5.5) 4.6 - 8

Double Indicator
Protein : Nil Nil - Trace

Protein error of Indicator
Glucose : Nil Nil

GOD-POD
Urobilinogen : Normal Normal

Diazonium method / Modified Ehrlich reaction
Bilirubin : Negative Negative

Diazonium method
Ketones : Negative Negative

Nitroprusside reaction
Nitrites : Negative Negative

Diazonium method
Microscopic Examination
Pus Cells : 6-8/HPF 0 - 5 Cells / HPF
R.B.C : Nil 0 - 2 Cells / HPF
Epithelial Cells : 1-2/HPF
Casts : Nil Nil
Crystals : Nil Nil
Method : Photoelectric Color Comparison, Reagent Strip method & Microscopy

.
Method : Photo-Electric Color comparision/Reagent Strip Method/Manual Microscopy
DR.LATA M


CBP (COMPLETE BLOOD PICTURE) WB EDTA

Haemoglobin : 15.9 13.0 - 17.0 g/dL

Photometry
Total RBC Count : 5.45 4.5 - 5.5 millions/cumm

Impedance
Packed Cell Volume / Hematocrit : 47.30 40.0 - 50.0 Vol%

Numeric Integration of the MCV
MCV : 87.00 83.0 - 101.0 fl

Calculation
MCH : 29.10 27 - 32 pg
Calculation
MCHC : 33.50 31.5 - 34.5 gm/dL

Calculation
RDW : 11.9 11.6 - 14.0 %

Calculation
Total WBC Count : 7,700 4000 - 10000 Cells/cumm

Impedance
Differential count
Neutrophils : 60 40 - 80 %
Impedance with Hydrofocus / Microscopy
Lymphocytes : 32 20 - 40 %
Eosinophils : 04 1-6 %
Monocytes : 04 2 - 10 %
Basophils : 00 0-2 %
Impedance
Absolute Leucocyte Count
Absolute Neutrophil Count : 4620 2000 - 7000 Cells/cumm

Absolute Lymphocyte Count : 2464 1000 - 3000 Cells/cumm

Absolute Eosinophil Count : 308 20 - 500 Cells/cumm

Absolute Monocyte Count : 308 200 - 1000 Cells/cumm



CBP (COMPLETE BLOOD PICTURE) WB EDTA

Platelet Count : 2,80,000 150000 - 410000 /cumm

Impedance
Peripheral Smear
RBC : Normocytic Normochromic

Microscopy of Leishman stained smear
WBC : Normal in morphology,maturity and distribution

Platelets : Adequate
DR.PRADEEP


T3,T4 & TSH SERUM

T3 : 0.89 0.87 - 1.78 ng/mL

T4 : 7.79 6.09 - 12.23 µg/dL

T.S.H : 1.47 0.34 - 5.60 µIU/mL

---------------------------------
- Patient preparation is particularly important for hormone studies, results of which may markedly effected by
many factors such as stress, position, fasting state, time of the day, preceding diet & drug therapy.
- The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hyperthyroidism.
- T3 is not recommended for diagnosis of hypothyroidism as decreased values have minimal clinical significance.
- Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic
stress and hypothyroidism.
- Elevated level of T4 are seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG.
- Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in TBG.
- TSH control biosynthesis and release of thyroid hormones T3 & T4.
- TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos
thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium and iodine induced or deficiency
goiter.
- Decrease in TSH levels are seen in Toxic multinodular goiter, thyroid adenoma, Graves disease, thyroiditis, extrathyroidal
thyroid hormone source, over replacement of thyroid hormone in treatment of hypothyroidism, secondary hypothyroidism,
severe dehydration, first trimester of pregnancy.
Dr NARENDER G MD
Certificate # MC-2025 CONSULTANT BIOCHEMIST


Sample Type : Whole Blood Citrate Ref no. :
ESR (ERYTHROCYTE SEDIMENTATION RATE)

Erythrocyte Sedimentation Rate (ESR) : 1st hour 10 mm 0 - 15 mm/hr

Method : (Modified Westergrens Method)
----------------------------------
- ESR is a nonspecific phenomenon, clinically useful in disorders associated with an increased production of acute phase proteins.
- Elevated in acute and chronic infections and malignancies.
- Extremely high ESR values are seen in multiple myeloma, leukemia, lymphoma, breast and lung carcinomas, rtheumatoid
arthritis, SLE, pulmonary infarction.
DR.PRADEEP


GLYCOSYLATED HAEMOGLOBIN (HbA1c)
Glycosylated Haemoglobin : 6.1 Non Diabetic : < 5.6%

Prediabetic Range : 5.7 - 6.4%
Diabetic Range : > 6.5%
Method : High Performance Liquid Chromatography (HPLC)
---------------------------------
- Glycosylated hemoglobin is proportional to mean plasma glucose level during previous 6-12 weeks.
- Values may not be comparable with different methodologies and even different laboratories using the same methodology.
- Perform A1c at least twice annually in Diabetes patients to ascertain meeting of goals
- Perform A1c test quarterly in Diabetes patients whose therapy has changed and who are not meeting goals
- Recommended goal of A1c is < 7%
- ADA Guidelines 2019.
Released Date : 02/11/2019 10:18 Page 1 of 2

*401975639*

DR.PRADEEP
CONSULTANT PATHOLOGIST
Released Date : 02/11/2019 10:18 Page 2 of 2

*401975639*
Patient report
Bio-Rad DATE: 11/02/2019
D-10 TIME: 10:06 AM
S/N: #DJ8G550402 Software version: 4.30-2
Sample ID: 401975639
Injection date 11/02/2019 10:02 AM
Injection #: 10 Method: HbA1c
Rack #: --- Rack position: 10
Peak table - ID: 401975639

Peak R.time Height Area Area %
A1a 0.20 8205 27057 0.7
A1b 0.29 14874 73570 1.9
LA1c/CHb-1 0.68 6686 57266 1.5
A1c 0.89 15705 165761 6.1
P3 1.38 54972 197646 5.2
A0 1.44 952762 3281722 86.3
Total Area: 3803023
Concentration: %
A1c 6.1

WMTC1498

Uploaded by

Copyright:

Available Formats

WMTC1498

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

WMTC1498

Uploaded by

Copyright:

Available Formats

Vijaya Diagnostic Centre

H.No.6-3-28/29, Beside Joyalukkas Jewellers, Hanamkonda.

LABORATORY TEST REPORT

Uric Acid : 8.1 3.5 - 7.2 mg/dL

Serum Calcium : 9.1 8.8 - 10.6 mg/dL

Creatinine : 2.0 Adult Male : 0.7 - 1.2 mg/dL

Urea : 45 Adults: 17-43mg/dL

Released Date 02/11/2019 11:17 Page 1 of 12

LABORATORY TEST REPORT

PSA ONLY FOR MEN (PROSTATE SPECIFIC ANTIGEN)

Serum Prostatic Specific Antigen : 1.92 <4.0 ng/mL

Released Date 02/11/2019 11:17 Page 2 of 12

LABORATORY TEST REPORT

FASTING PLASMA GLUCOSE (FPG)

Fasting Plasma Glucose : 103 Normal : 70-100 mg/dL

Released Date 02/11/2019 10:18 Page 3 of 12

LABORATORY TEST REPORT

BLOOD GROUPING & Rh TYPING

ABO Group : "O"

Released Date 02/11/2019 10:59 Page 4 of 12

LABORATORY TEST REPORT

Hepatitis B Surface Antigen (HBsAg) - Rapid

HBsAg (Spot) : Negative NA

Released Date 02/11/2019 10:43 Page 5 of 12

LABORATORY TEST REPORT

LIPID PROFILE (LP)

Serum Status : Clear

Triglycerides : 171 Desirable Level : < 150 mg/dL

Total Cholesterol : 243 Desirable Level : < 200 mg/dL

LDL Cholesterol. : 174 Optimal : < 100 mg/dL

HDL Cholesterol : 35 Desirable Level : > 60 mg/dL

VLDL : 34 < 30 mg/dL

Total Cholesterol/HDL Cholesterol Ratio : 6.94 Low Risk : 3.3 - 4.4

LDL Cholesterol/HDL Cholesterol Ratio : 4.97 Desirable Level : 0.5 - 3.0

Released Date 02/11/2019 10:18 Page 6 of 12

LABORATORY TEST REPORT

LIVER FUNCTION TEST - A (LFT-A)

Total Bilirubin : 1.3 0.3 - 1.2 mg/dL

Conjugated Bilirubin : 0.2 Less than 0.2 mg/dL

Unconjugated Bilirubin : 1.1 0.3 - 1.00 mg/dL

ALT/SGPT : 13 Male (Adult) : 0 - 50 U/L

AST/SGOT : 14 Male (Adult) : 0 - 50 U/L

Alkaline Phosphatase : 95 30 - 120 U/L

Total Protein (TP) : 7.2 6.6 - 8.3 g/dL

Albumin : 4.2 Adult : 3.5 - 5.2 g/dL

Globulin : 3.0 1.8 - 3.6 g/dL

Albumin / Globulin (A/G) Ratio : 1.4 0.8 - 2.0

Gamma-Glutamyl Transferase (GGT) : 34 0 - 55 U/L

Released Date 02/11/2019 10:18 Page 7 of 12

LABORATORY TEST REPORT

CUE (COMPLETE URINE EXAMINATION)

Colour : Pale Yellow Pale Yellow

Appearance : Clear Clear

Specific Gravity : 1.015 1.003 - 1.030

Reaction/pH : Acidic (5.5) 4.6 - 8

Protein : Nil Nil - Trace

Glucose : Nil Nil

Urobilinogen : Normal Normal

Bilirubin : Negative Negative